Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using (/sup 125/I)Bolton Hunter-cholecystokinin octapeptide

Journal Article · · J. Pharmacol. Exp. Ther.; (United States)
OSTI ID:5483392

(/sup 125/I)Bolton Hunter-cholecystokinin octapeptide (BH-CCK8) has been prepared using a modified method and was used to study putative cholecystokinin (CCK) receptor sites in the guinea-pig cerebral cortex. Specific binding of (/sup 125/I)BH-CCK8, defined as the difference in binding in the absence and presence of 10(-6) M CCK8, was 70% of total binding. In saturation experiments, the apparent dissociation constant (K/sub d/) was 1 nM and total binding capacity was 28 fmol/mg of protein. In association experiments, conducted at 30 degrees C, binding of (/sup 125/I)BH-CCIK8 reached equilibrium in approximately 150 min. Binding was stable for 4 hr and was reversed by the addition of unlabeled CCK8-sulfated. Dissociation of bound ligand was biphasic and the apparent T/sub 1/2 was 45 min. Analyses of kinetic experiments yielded an association rate constant of 0.58 x 10(8) min/sup -1/ M/sup -1/ and a dissociation rate constant for the slower component of 0.012 min/sup -1/. Dithiothreitol increased and N-ethylmaleimide decreased specific binding of (/sup 125/I)BH-CCK8, indicating that CCK receptor sites involve sulfhydryl groups. In competition experiments, the potency of CCK4 was enhanced 50-fold with addition of protease inhibitors. The rank order of CCK-related peptides was CCK8-sulfated greater than or equal to Gastrin 17 greater than or equal to CCK33 greater than CCK4 greater than or equal to CCK8-desulfated. Proglumide, a proposed CCK antagonist in the periphery and brain, was inactive at 10(-3) M. The specificity of (/sup 125/I)BH-CCK8 binding sites are similar to that reported for (/sup 125/I)BH-CCK33.

Research Organization:
Abbott Labs., North Chicago, IL
OSTI ID:
5483392
Journal Information:
J. Pharmacol. Exp. Ther.; (United States), Journal Name: J. Pharmacol. Exp. Ther.; (United States) Vol. 232:3; ISSN JPETA
Country of Publication:
United States
Language:
English